Day: February 4, 2022
Valoe Corporation Stock Exchange Release 4 February 2022 at 12.15 Finnish time
Further to the announcement of 30 July 2021, Valoe Corporation (“Valoe”) has completed the drawdown of an advance of EUR 300,000, pursuant to the terms and conditions of the Financing Agreement between Valoe and RiverFort Global Opportunities Pcc Limited (“RiverFort”).
Following the drawdown of the advance Valoe will grant 931,677 warrants to RiverFort. Valoe has settled transaction fees of EUR 27,000 by the transfer of a total of 335,404 treasury shares.
Valoe and RiverFort have separately agreed to reduce the outstanding balance of the Advances withdrawn earlier by approx. EUR 0.1 million including part of the principal and interests of the Advances through RiverFort electing to subscribe for shares in Valoe....
Atotech Names Klaus-Günter Vennemann to Board of Directors; Brian Bernasek Resigns as Director
Written by Customer Service on . Posted in Public Companies.
BERLIN, Feb. 04, 2022 (GLOBE NEWSWIRE) — Atotech (NYSE: ATC), a leading specialty chemicals technology company and a market leader in advanced electroplating solutions, announced today that Brian Bernasek, a member of the company’s Board of Directors, has resigned as a director as of January 31, 2022.
The Board has appointed Klaus-Günter Vennemann as a Director and a member of the Board’s Audit Committee, effective February 1, 2022.
Mr. Vennemann is a management consultant and a member of the Supervisory Board of Rheinmetall since 2016. He was previously the CEO of the General Lighting business unit of OSRAM AG.
The Board has determined that Mr. Vennemann is an independent director within the meaning of the New York Stock Exchange listing standards.
About AtotechAtotech is a leading specialty chemicals technology company and a...
PRESS RELEASE: BIGBEN: Confirmation of the distribution ratio and implementation of the exceptional distribution in kind of Nacon shares
Written by Customer Service on . Posted in Public Companies.
Bigben Press release
Lesquin, 4 February 2022, 11hrs
Confirmation of the distribution ratio and Implementation of the exceptional distribution in kind of Nacon shares
BIGBEN INTERACTIVE (“BBI” or the “Company”) informs its shareholders that given the opening price of Nacon shares on the regulated market of Euronext in Paris, its Board of Directors meeting today confirmed the distribution ratio of one (1) Nacon share for every five (5) BBI shares held.
Following the approval of the transaction by BBI’s shareholders at the Combined General Meeting on January 28, 2022, the exceptional distribution in kind of Nacon shares to BBI’s shareholders is effective as of today, the date of the payment.
Following this transaction, BBI will hold 61,244,666 Nacon...
Fortuna pursues clarification from Mexican authorities on term of the Environmental Impact Authorization
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Feb. 04, 2022 (GLOBE NEWSWIRE) — Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) reports that on January 28, 2022 it received a notice (the “Notice”) from the Secretaría de Medio Ambiente y Recursos Naturales (“SEMARNAT”) which advised that SEMARNAT has made a typographical error in the extension to the term of the environmental impact authorization (“EIA”) for the San Jose Mine, located in Oaxaca, Mexico.
On December 17, 2021, SEMARNAT granted the Company a 12 year extension (the “EIA Extension”) to the EIA for the San Jose Mine (refer to Fortuna news release dated December 20, 2021) which expires in October 2033. However, the Notice states that SEMARNAT has made a typographical error in the EIA Extension and that the correct term is two years.
The Company is of the view that the Notice was issued...
Presentation of Q4 and 12M 2021 financial result
Written by Customer Service on . Posted in Public Companies.
Attached is the presentation of Q4 and 12M 2021 financial results.AttachmentQ4 2021 Presentation
Terranet Announces CEO’s Termination with Immediate Effect
Written by Customer Service on . Posted in Public Companies.
Lund, February 4, 2022. Terranet AB (Nasdaq: TERRNT-B), a tech company that provides advanced driver assistance systems (ADAS) for the automotive industry announced today that the Board of Directors has terminated Pär-Olof Johannesson’s employment as CEO of Terranet AB (publ.) (“Terranet”) with immediate effect. Terranet’s Chairman Göran Janson has taken over as interim CEO until a successor is put in place.
Göran Janson has a long and successful career with advanced tech companies and leading global organizations.
The process of recruiting a successor CEO that will lead the company on its continued growth journey, has been initiated.
For more information: Göran Janson
Chairman of the Board
goran.janson@terranet.se
Thomas Falkenberg
CFO thomas.falkenberg@terranet.se+ 46 703 360 346
About Terranet Terranet AB (Nasdaq: TERRNT-B). With...
HUTCHMED Initiates Phase Ib/II Study of HMPL-453 in Combination with Chemotherapy or Toripalimab for Advanced Solid Tumors in China
Written by Customer Service on . Posted in Public Companies.
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Feb. 04, 2022 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated a Phase Ib/II study in China of HMPL-453, an investigational novel selective inhibitor targeting fibroblast growth factor receptors (“FGFR”) 1/2/3, in combination with chemotherapy or the anti-PD-1 therapy, toripalimab. The first patient received their first dose on January 22, 2022.
The clinical trial is a multi-center, two-stage, open-label study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy profile of HMPL-453 combination therapy in patients with specific advanced or metastatic solid tumors.
The first stage of the study is a dose escalation phase to determine the dose limiting toxicity (DLT) and recommended...
SpareBank 1 SMN: SpareBank 1 Gruppen – result 4th quarter and the final year end of 2021
Written by Customer Service on . Posted in Public Companies.
SpareBank 1 SMN has an ownership share of 19.5 % in SpareBank 1 Gruppen AS. SpareBank 1 SMN’s controlling interest share of SpareBank 1 Gruppen’s profit after tax in the 4th quarter was NOK 173 (86) *million. SpareBank 1 SMN’s share of SpareBank 1 Gruppen’s profit after tax as of 31 December 2021 was NOK 471 (193) million. The SpareBank 1 Gruppen’s profit before tax as of 31 December 2021 was NOK 4,153(1,817) million. Profit after tax was NOK 3,250 (1,393) million. The controlling interest’s share of the profit in the 4th quarter and as of 31 December 2021 was resp. NOK 888(439) and NOK 2,415(988) million. Profit before and after tax in the fourth quarter was resp. NOK 1,337 (764) million and NOK 1,080 (594) million. Fremtind, which is owned 65% by SpareBank 1 Gruppen AS, had a profit before tax of NOK 678 (583) million in...
Alfa Beta Brand President Vassilis Stavrou to leave Ahold Delhaize
Written by Customer Service on . Posted in Public Companies.
Zaandam, the Netherlands, February 4, 2022 – Vassilis Stavrou, Brand President of Alfa Beta, has decided to leave Ahold Delhaize. Stavrou started his career at the company 28 years ago, as warehouse manager. He took on roles in Quality Assurance and Food Safety afterwards, before transitioning to Human Resources. From there Stavrou transitioned to roles within Delhaize Group where he held responsibility as SVP Human Resources, Organizational Development & Sustainability and ultimately Business Development. He was then appointed Brand President for Mega Image in Romania. After which he was appointed to Brand President at Alfa Beta in Greece in 2018.
Wouter Kolk, CEO Ahold Delhaize Europe & Indonesia: “I would like to take this opportunity to thank Vassilis who made many contributions during his varied and longstanding...
Mainz Biomed Initiates Clinical Study to Evaluate Integrating Novel mRNA Biomarkers Into ColoAlert
Written by Customer Service on . Posted in Public Companies.
Results to impact ColoAlert profile for FDA submission
Provides opportunity for ColoAlert to achieve gold standard status as the premier at-home screening test for colorectal cancer
BERKELEY, Calif. and MAINZ, Germany, Feb. 04, 2022 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today it has commenced ColoFuture, an international clinical study to evaluate the potential to integrate a portfolio of novel mRNA biomarkers into ColoAlert, the Company’s highly efficacious, and easy-to-use detection test for colorectal cancer which is being commercialized across Europe. The novel gene expression (mRNA) biomarkers, which we acquired an exclusive option to in-license from the Université de Sherbrooke in...